Treatment of Orbital Cellulitis with Cavernous Sinus Thrombosis, Severe Loss of Visual Acuity, and Cranial Nerve Involvement
Orbital cellulitis complicated by cavernous sinus thrombosis (CST) is a neurologically critical emergency. Severe visual acuity loss is a key clinical warning sign, and involvement of cranial nerves heightens the urgency for a structured, multidisciplinary management approach.
Clinical Scenario
This protocol is indicated when orbital cellulitis presents alongside cavernous sinus thrombosis with severe loss of visual acuity. Deficit or dysfunction of cranial nerves III, IV, V, or VI in this context carries strong clinical suspicion for CST and marks a high-acuity presentation requiring immediate action.
Treatment Approach
Management is anchored by broad-spectrum antimicrobial therapy directed at both aerobic and anaerobic organisms — the complete structured regimen, covering the full therapeutic sequence and surgical considerations, is available in the protocol below.
References
- CST should be suspected clinically when there is severe loss of visual acuity.
- Involvement of the III, IV, V or VI cranial nerves adds a strong clinical suspicion for CST.
- CST is generally treated with broad-spectrum antibiotics that cover against aerobic and anaerobic organisms (vancomycin, a cephalosporin, and metronidazole).
DOI: 10.1016/j.survophthal.2017.12.001
View source ↗